Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis G. Caleb Alexander, MD, MS, Geetha Iyer, MBBS, Eleanor Lucas, BA, Dora Lin, MHS, Sonal Singh, MD The American Journal of Medicine Volume 130, Issue 3, Pages 293-305 (March 2017) DOI: 10.1016/j.amjmed.2016.09.017 Copyright © 2016 Elsevier Inc. Terms and Conditions
Figure 1 Risk of bias assessment of the included randomized controlled trials using the Cochrane Risk of Bias Tool. The American Journal of Medicine 2017 130, 293-305DOI: (10.1016/j.amjmed.2016.09.017) Copyright © 2016 Elsevier Inc. Terms and Conditions
Figure 2 (A) Exogenous testosterone and myocardial infarction. (B) Exogenous testosterone and stroke. (C) Exogenous testosterone and mortality. (D) Exogenous testosterone and composite outcome of myocardial infarction, stroke, and mortality. The American Journal of Medicine 2017 130, 293-305DOI: (10.1016/j.amjmed.2016.09.017) Copyright © 2016 Elsevier Inc. Terms and Conditions
Figure 2 (A) Exogenous testosterone and myocardial infarction. (B) Exogenous testosterone and stroke. (C) Exogenous testosterone and mortality. (D) Exogenous testosterone and composite outcome of myocardial infarction, stroke, and mortality. The American Journal of Medicine 2017 130, 293-305DOI: (10.1016/j.amjmed.2016.09.017) Copyright © 2016 Elsevier Inc. Terms and Conditions